The scenario may be different in patients with deep infiltrating endometriosis (DIE), which is characterized by the suppression of 17β-HSDs 2 and 4 along with increased expression of aromatase and 17β-HSD1 [66]. The gene discussed is CYP19A1; the disease is endometriosis.